Search Results - "Scharnagl, H."

Refine Results
  1. 1

    Maternal obesity modulates intracellular lipid turnover in the human term placenta by Hirschmugl, B, Desoye, G, Catalano, P, Klymiuk, I, Scharnagl, H, Payr, S, Kitzinger, E, Schliefsteiner, C, Lang, U, Wadsack, C, Hauguel-de Mouzon, S

    Published in International Journal of Obesity (01-02-2017)
    “…Background: Obesity before pregnancy is associated with impaired metabolic status of the mother and the offspring later in life. These adverse effects have…”
    Get full text
    Journal Article
  2. 2
  3. 3

    C-reactive protein predicts mortality in patients referred for coronary angiography and symptoms of heart failure with preserved ejection fraction by Koller, L., Kleber, M., Goliasch, G., Sulzgruber, P., Scharnagl, H., Silbernagel, G., Grammer, T., Delgado, G., Tomaschitz, A., Pilz, S., März, W., Niessner, A.

    Published in European journal of heart failure (01-07-2014)
    “…Aims Heart failure with preserved ejection fraction (HFpEF) has a different pathophysiological background compared to heart failure with reduced ejection…”
    Get full text
    Journal Article
  4. 4

    LONG- AND SHORT-TERM ASSOCIATION OF LOW-GRADE SYSTEMIC INFLAMMATION WITH CARDIOVASCULAR MORTALITY by Kälsch, A.-I, Kleber, M, Sattler, W, Krämer, B.K, März, W, Malle, E, Leipe, J, Scharnagl, H

    Published in Journal of hypertension (01-07-2019)
    “…OBJECTIVE:Atherosclerosis is a chronic inflammatory disease and atherosclerotic diseases represent the leading cause of death worldwide. Proinflammatory…”
    Get full text
    Journal Article
  5. 5

    Copper, ceruloplasmin, and long-term cardiovascular and total mortality (the Ludwigshafen Risk and Cardiovascular Health Study) by Grammer, T B, Kleber, M E, Silbernagel, G, Pilz, S, Scharnagl, H, Lerchbaum, E, Tomaschitz, A, Koenig, W, März, W

    Published in Free radical research (01-06-2014)
    “…Copper and its main transport protein ceruloplasmin have been suggested to promote the development of atherosclerosis. Most of the data come from experimental…”
    Get more information
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Cerebrospinal fluid lipocalin 2 in patients with clinically isolated syndromes and early multiple sclerosis by Khalil, M, Renner, A, Langkammer, C, Enzinger, C, Ropele, S, Stojakovic, T, Scharnagl, H, Bachmaier, G, Pichler, A, Archelos, JJ, Fuchs, S, Seifert-Held, T, Fazekas, F

    Published in Multiple sclerosis (01-10-2016)
    “…Background: Lipocalin 2 (LCN2) may be involved in the immunopathogenesis of multiple sclerosis (MS) and might further impact on iron homoeostasis. Brain iron…”
    Get full text
    Journal Article
  11. 11

    Effects of Vitamin D3 on asymmetric- and symmetric dimethylarginine in arterial hypertension by Grübler, M.R., Gaksch, M., Kienreich, K., Verheyen, N.D., Schmid, J., Müllner, C., Richtig, G., Scharnagl, H., Trummer, C., Schwetz, V., Meinitzer, A., Pieske, B., März, W., Tomaschitz, A., Pilz, S.

    “…•Vitamin D is suggested to be a protective factor for CV-diseases. The potential mechanism might be based on endothelial function.•We conducted a double-blind…”
    Get full text
    Journal Article
  12. 12

    Effects of vitamin D supplementation on glycated haemoglobin and fasting glucose levels in hypertensive patients: a randomized controlled trial by Grübler, M. R., Gaksch, M., Kienreich, K., Verheyen, N., Schmid, J., ó Hartaigh, B., Richtig, G., Scharnagl, H., Meinitzer, A., Fahrleitner-Pammer, A., März, W., Tomaschitz, A., Pilz, S.

    Published in Diabetes, obesity & metabolism (01-10-2016)
    “…Aim To investigate the efficacy of vitamin D supplementation on glycaemic control. Methods The Styrian Vitamin D Hypertension Trial was a single‐centre,…”
    Get full text
    Journal Article
  13. 13

    Expression of fat mobilizing genes in human epicardial adipose tissue by Jaffer, I, Riederer, M, Shah, P, Peters, P, Quehenberger, F, Wood, A, Scharnagl, H, März, W, Kostner, K.M, Kostner, G.M

    Published in Atherosclerosis (01-01-2012)
    “…Abstract Background Epicardial adipose tissue (EAT) mass correlates with Metabolic Syndrome and coronary artery disease (CAD). However, little is known about…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    C-reactive protein and lipoprotein-associated phospholipase A2 in smokers and nonsmokers of the Ludwigshafen Risk and Cardiovascular Health study by Kleber, M E, Siekmeier, R, Delgado, G, Grammer, T B, Winkelmann, B R, Scharnagl, H, Boehm, B O, März, W

    “…Measurement of high sensitivity CRP (hsCRP) and lipoprotein-associated phospholipase A2 (LpPLA2) provides information on systemic inflammation and stability of…”
    Get more information
    Journal Article
  18. 18

    Independent associations of vitamin D metabolites with anemia in patients referred to coronary angiography: the LURIC study by Ernst, J. B., Zittermann, A., Pilz, S., Kleber, M. E., Scharnagl, H., Brandenburg, V. M., König, W., Grammer, T. B., März, W.

    Published in European journal of nutrition (01-04-2017)
    “…Purpose Anemia and vitamin D deficiency are both frequent in adult patients. Whether low vitamin D metabolite levels are an independent risk factor for…”
    Get full text
    Journal Article
  19. 19

    Inflammation-associated graft loss in renal transplant recipients by Dahle, Dag Olav, Mjøen, Geir, Öqvist, Björn, Scharnagl, Hubert, Weihrauch, Gisela, Grammer, Tanja, März, Winfried, Abedini, Sadollah, Norby, Gudrun E., Holme, Ingar, Fellström, Bengt, Jardine, Alan, Holdaas, Hallvard

    Published in Nephrology, dialysis, transplantation (01-11-2011)
    “…Background. Although short-term graft survival has improved substantially in renal transplant recipients, long-term graft survival has not improved over the…”
    Get full text
    Journal Article
  20. 20